Skip to search.
 TSX Down 0.01% TSX Ventures Up 0.38%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
85.13 Down 1.79(2.06%) 2:11PM EST - Nasdaq Real Time Price
Prev Close:86.92
Open:86.34
Bid:85.19 x 400
Ask:85.27 x 300
1y Target Est:113.67
Beta:1.97922
Earnings Date:Feb 23 - Feb 27 (Est.)
Day's Range:84.43 - 86.54
52wk Range:62.12 - 102.49
Volume:735,003
Avg Vol (3m):1,300,810
Market Cap:14.64B
P/E (ttm):N/A
EPS (ttm):-2.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMRNDown 2.06%14.64B
FOLDDown 7.23%785.64M
1 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.31
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-3.73
Quarterly EPS Est (Dec-16) :-0.38
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-0.93

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback